MedPath

University of Guadalajara

University of Guadalajara logo
🇲🇽Mexico
Ownership
Private
Established
1792-01-01
Employees
-
Market Cap
-
Website
http://www.udg.mx

Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.

Phase 4
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2015-11-03
Last Posted Date
2020-10-09
Lead Sponsor
University of Guadalajara
Target Recruit Count
18
Registration Number
NCT02595684
Locations
🇲🇽

Instituto de Terapéutica Experimental y Clínica, Guadalajara, Jalisco, Mexico

Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus

Phase 2
Terminated
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2015-09-15
Last Posted Date
2018-05-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
22
Registration Number
NCT02549924
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Bezafibrate Plus Berberine in Mixed Dyslipidemia

Phase 3
Completed
Conditions
Mixed Dyslipidemia
Interventions
First Posted Date
2015-09-14
Last Posted Date
2023-02-24
Lead Sponsor
University of Guadalajara
Target Recruit Count
36
Registration Number
NCT02548832
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease

Phase 1
Completed
Conditions
Fibrosis
Chronic Kidney Disease
Interventions
First Posted Date
2015-04-03
Last Posted Date
2015-04-03
Lead Sponsor
University of Guadalajara
Target Recruit Count
30
Registration Number
NCT02408744

Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion

Phase 2
Completed
Conditions
Diabetes Mellitus Type 2
Interventions
First Posted Date
2015-03-25
Last Posted Date
2020-10-22
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02397447
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin

Phase 2
Completed
Conditions
Metabolic Syndrome
Interventions
First Posted Date
2015-02-24
Last Posted Date
2019-06-18
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02370121

Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

Not Applicable
Completed
Conditions
Metabolic Syndrome X
Interventions
Other: Placebo
Dietary Supplement: Irvingia gabonensis
First Posted Date
2015-02-03
Last Posted Date
2020-10-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02354339
Locations
🇲🇽

Instituto de Terapéutica Experimental y Clínica, Guadalajara, Jalisco, Mexico

Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome

Phase 2
Completed
Conditions
Metabolic Syndrome X
Interventions
Drug: Placebo
First Posted Date
2015-01-14
Last Posted Date
2020-10-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02337933
Locations
🇲🇽

Instituto de Terapéutica Experimental y Clínica, Guadalajara, Jalisco, Mexico

Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion

Not Applicable
Completed
Conditions
Glucose Intolerance
Interventions
Other: Placebo
Dietary Supplement: Artemisia dracunculus
First Posted Date
2015-01-01
Last Posted Date
2020-10-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02330341
Locations
🇲🇽

Manuel González Ortiz, Guadalajara, Jalisco, Mexico

Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Phase 2
Completed
Conditions
Fibrosis
Hepatitis C Chronic
Interventions
Drug: Matched equivalent placebo
First Posted Date
2014-06-12
Last Posted Date
2014-07-09
Lead Sponsor
University of Guadalajara
Target Recruit Count
150
Registration Number
NCT02161952
© Copyright 2025. All Rights Reserved by MedPath